Cardiff R D
Adv Cancer Res. 1984;42:167-90. doi: 10.1016/s0065-230x(08)60458-3.
The mouse mammary tumor virus has provided a window into the inner workings of the mammary epithelial cell at the earliest stages of neoplasia. Techniques of molecular biology permitted us to look through that window revealing a new biology which deserves consideration as a model for mammary tumorigenesis in all species. According to this model the neoplastic process originates in a single mammary epithelial cell as a result of a critical genetic alteration, such as integration of MuMTV (MuMHV) into a key site in the mouse genome (Fig. 4). The genetic alteration immortalizes the cell and provides it with selective growth advantages which result in a clonal proliferation. This original proliferation emerges as the protoneoplastic mammary hyperplasia. The protoneoplastic cells have limited growth potential and are not obligated to undergo malignant transformation but they represent a genetically evolving population highly susceptible to full blown malignancy after exposure to carcinogens. Protoneoplastic cells which undergo further genetic alterations that provide additional selective growth advantages proliferate and emerge as malignant tumors. The genetic alterations are sometimes reflected by changes in viral DNA but this is not essential and most mouse mammary tumors probably do not occur as the result of new host-virus interactions. No doubt the current work on the mouse "int" loci will help define the genes responsible for the induction and maintenance of the protoneoplastic state. Since such host genes have proven so ubiquitous, one must also predict that analogous genes will be found in human mammary protoneoplasias. Detection of such sequences may help distinguish protoneoplastic processes from nonneoplastic, low risk hyperplasias in the human breast. Finally, the gene or genes involved in the more lethal malignant transformation await elucidation. Based on past and current progress one can be sure that the mouse mammary tumor system will help point the way.
小鼠乳腺肿瘤病毒为我们提供了一个窗口,使我们能够窥探到肿瘤形成最早阶段乳腺上皮细胞的内部运作机制。分子生物学技术让我们得以透过这扇窗口,揭示出一种全新的生物学现象,这种现象值得作为所有物种乳腺肿瘤发生的模型加以研究。根据这个模型,肿瘤形成过程起源于单个乳腺上皮细胞,是由关键的基因改变引发的,比如小鼠乳腺肿瘤病毒(MuMTV,即MuMHV)整合到小鼠基因组的关键位点(图4)。这种基因改变使细胞永生化,并赋予其选择性生长优势,从而导致克隆性增殖。这种最初的增殖表现为肿瘤前乳腺增生。肿瘤前体细胞的生长潜能有限,并非一定会发生恶性转化,但它们代表了一个基因不断演变的群体,在接触致癌物后极易发展为完全恶性肿瘤。经历进一步基因改变从而获得额外选择性生长优势的肿瘤前体细胞会增殖,并发展为恶性肿瘤。基因改变有时会通过病毒DNA的变化体现出来,但这并非必要条件,大多数小鼠乳腺肿瘤可能并非新的宿主 - 病毒相互作用的结果。毫无疑问,目前关于小鼠“int”基因座的研究工作将有助于确定负责诱导和维持肿瘤前状态的基因。由于此类宿主基因已被证明极为普遍,因此人们也必定会预测在人类乳腺肿瘤前病变中会发现类似的基因。检测此类序列可能有助于区分人类乳腺中的肿瘤前病变过程与非肿瘤性、低风险增生。最后,参与更具致命性恶性转化的一个或多个基因仍有待阐明。基于过去和当前的进展,可以确定小鼠乳腺肿瘤系统将有助于指明方向。